| GENE SYMBOL |
# PUBMED REF |
# CANCER LIT |
DESCRIPTION |
| BCL6 |
3842 |
3708 |
B-CELL LYMPHOMA 6; BCL6, BCL6/H4FM FUSION GENE, INCLUDED |
| PPARG |
1394 |
263 |
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, PAX8/PPARG FUSION |
| LPP |
456 |
26 |
LIM DOMAIN-CONTAINING PREFERRED TRANSLOCATION PARTNER IN LIPOMA, LPP/MLL FUSION, LPP/HMGIC FUSION |
| EVI1 |
98 |
70 |
ECOTROPIC VIRAL INTEGRATION SITE 1, AML1 in the 3;21 translocations: EVI1, EAP (180474), and MDS1 (600049). TEL--EAP--MDS1-- |
| MDS1 |
60 |
39 |
MDS1/AML1 FUSION GENE, AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL |
| MLF1 |
3627 |
3416 |
MYELOID LEUKEMIA FACTOR 1 |
| CTNNB1 |
3524 |
1737 |
BETA-CATENIN |
| VHL |
1302 |
1066 |
VON HIPPEL-LINDAU SYNDROME |
| MLH1 |
1059 |
890 |
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2 |
| XPC |
529 |
461 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C |
| TERC |
422 |
215 |
TELOMERASE RNA COMPONENT |
| TP73L |
201 |
100 |
TUMOR PROTEIN p73-LIKE |
| THRB |
921 |
98 |
THYROID HORMONE RECEPTOR, BETA |
| FANCD2 |
68 |
42 |
FANCONI ANEMIA, COMPLEMENTATION GROUP D2 |
| ATR |
137 |
35 |
ATAXIA-TELANGIECTASIA AND RAD3-RELATED |
| PIK3CA |
92 |
27 |
PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, ALPHA |
| ARMET |
65 |
17 |
ARGININE-RICH, MUTATED IN EARLY STAGE TUMORS |
| TDGF1 |
18 |
11 |
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1 |
| RAB7 |
217 |
8 |
RAS-ASSOCIATED PROTEIN RAB7 |
| DIRC2 |
6 |
6 |
DISRUPTED IN RENAL CARCINOMA 2 |
| EGI3 |
2312 |
69 |
EPILEPSY, JUVENILE ABSENCE |
| DRD3 |
1393 |
16 |
DOPAMINE RECEPTOR D3, SCHIZOPHRENIA SUSEPTIBILITY |
| SPG14 |
435 |
44 |
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE |
| DM2 |
248 |
0 |
MYOTONIC MYOPATHY PROXIMAL |
| SCA7 |
117 |
1 |
SPINOCEREBELLAR ATAXIA 7 |
| HMSNO |
33 |
0 |
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE |
| ETM1 |
26 |
0 |
TREMOR FAMILIAL ESSNTIAL 1 |
| HSN1B |
2 |
0 |
NEUROPATHY, HEREDITARY SENSORY, TYPE IB |
| AUTS3 |
67 |
3 |
AUTISM SUSCEPTIBILITY TO, 3 |
| DMT1 |
6 |
0 |
DEMENTIA, FAMILIAL, NONSPECIFIC |
| MRT2A |
1 |
0 |
MENTAL RETARDATION, NONSYNDROMIC, AUTOSOMAL RECESSIVE, 2A |
| VHL |
1302 |
1066 |
VON HIPPEL-LINDAU SYNDROME |
| SLC2A2 |
444 |
53 |
SOLUTE CARRIER FAMILY 2, GLUCOSE TRANSPORTER, LIVER/ISLET, Diabetes mellitus, noninsulin-dependent; Fanconi-Bickel syndrome |
| CCM3 |
268 |
104 |
CEREBRAL CAVERNOUS MALFORMATIONS-3 |
| AOMS1 |
244 |
30 |
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 1 |
| MHS4 |
181 |
2 |
MALIGNANT HYPERTHERMIA SUSCEPTIBILITY 4 |
| DYX5 |
92 |
1 |
DYSLEXIA, SPECIFIC 5 |
| BBS3 |
61 |
4 |
BARDET-BIEDL SYNDROME 3 |
| MFS2 |
59 |
5 |
MARFAN SYNDROME, TYPE II |
| MBS2 |
34 |
1 |
Moebius syndrome-2 |
| HSCRS2 |
27 |
2 |
HIRSCHSPRUNG DISEASE, SHORT SEGMENT, 2 |
| LRS1 |
24 |
0 |
LARSEN SYNDROME, AUTOSOMAL DOMINANT |
| ACAA1 |
17 |
0 |
Pseudo-Zellweger syndrome |
| SLSN3 |
10 |
4 |
Senior-Loken syndrome 3 |
| USH3A |
7 |
0 |
USHER SYNDROME |
| USH2B |
6 |
0 |
USHER SYNDROME, TYPE IIB |
| AGS1 |
4 |
0 |
Aicardi-Goutieres syndrome 1 |
| CCR5 |
5333 |
203 |
CHEMOKINE, CC MOTIF, RECEPTOR 5, AIDS-SUSCEPTIBILITY/RESISTENCE TO HIV INFECTION |
| CCR1 |
585 |
34 |
|
| CCR3 |
554 |
24 |
|
| CCR2 |
523 |
32 |
SUSCEPTIBILITY/RESISTENCE TO HIV INFECTION |
| CX3CR1 |
475 |
48 |
CHEMOKINE, CX3C MOTIF, RECEPTOR 1 |
| CCR4 |
352 |
28 |
|
| CCR8 |
133 |
12 |
|
| CCR9 |
46 |
5 |
|
| XCR1 |
13 |
2 |
|
| CCRL2 |
1 |
0 |
|
| CCBP2 |
1 |
0 |
|
| TRH |
12420 |
1401 |
THYROTROPIN-RELEASING HORMONE |
| CTNNB1 |
3524 |
1737 |
BETA-CATENIN |
| THRB |
921 |
98 |
THYROID HORMONE RECEPTOR, BETA |
| PTHR1 |
353 |
49 |
PARATHYROID HORMONE RECEPTOR 1 |
| MITF |
283 |
66 |
MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR |
| SOX2 |
75 |
6 |
SRY-BOX 2 |
| DAZL |
62 |
1 |
DELETED IN AZOOSPERMIA-LIKE |
| HESX1 |
53 |
0 |
HOMEOBOX GENE EXPRESSED IN ES CELLS |
| POU1F1 |
28 |
1 |
POU DOMAIN, CLASS 1, TRANSCRIPTION FACTOR 1 |
| FOXL2 |
28 |
0 |
FORKHEAD TRANSCRIPTION FACTOR FOXL2 |
| DFNA18 |
4 |
0 |
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 18 |
| DFNB15 |
3 |
0 |
DEAFNESS AUTOSOMAL RECESSIVE 15 |
| TMIE |
2 |
0 |
TRANSMEMBRANE INNER EAR-EXPRESSED GENE |
| DFNA44 |
1 |
0 |
DEAFNESS AUTOSOMAL DOMINANT 44 |
| ATOD |
8116 |
224 |
DERMATITIS, ATOPIC |
| PSORS5 |
119 |
15 |
PSORIASIS SUSCEPTIBILITY 5 |
| ILVASC |
1 |
0 |
ICHTHYOSIS, LEUKOCYTE VACOULES, ALOPECIA AND SCLEROSING >CHOLANGITIS |
| ARVD5 |
637 |
5 |
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA |
| CMD1E |
1 |
0 |
CARDIOMYOPATHY, DILATED, 1E |
| SLC2A2 |
444 |
53 |
SOLUTE CARRIER FAMILY 2, GLUCOSE TRANSPORTER, LIVER/ISLET, DIABETES MELLITUS, NONINSULIN DEPENDENT; FANCONI-BICKEL SYNDROME |
| GLC1C |
6 |
0 |
GLAUCOMA 1C, PRIMARY OPEN ANGEL |